VanEck’s Dividend ETF Hits a Record High Just as a New Rival and Earnings Risks Converge

VanEck's TDIV ETF reaches a fresh high as Pfizer earnings, TotalEnergies results, and a divided Fed test momentum. A new ex-US dividend fund, TDVX, also debuts.

The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (TDIV) closed last week at €52.93, a fresh 12-month high and a gain of nearly 10% over the past year. But the fund enters a week packed with events that could test whether that momentum holds.

A New Irish Sibling Hits the Market

VanEck listed the VanEck Morningstar Developed Markets ex-US Dividend Leaders UCITS ETF (TDVX) on the London Stock Exchange on April 23. The new fund follows the same index methodology as TDIV but strips out all US equities.

The decision to launch a separate vehicle rather than modify the existing fund stems from structural constraints. TDIV is domiciled in the Netherlands, a setup that benefits Dutch investors on dividend withholding tax but prevents the introduction of an accumulating share class. Rather than redomicile the €7.4 billion fund to Ireland — a move that would have confused existing holders — VanEck opted for a standalone Irish-domiciled product. Ireland offers more favorable withholding tax terms on international securities and greater product flexibility.

The result is a bifurcated offering: TDIV for income-focused investors who prefer distributions, TDVX for those prioritizing accumulation and tax efficiency.

Pfizer Takes Center Stage

The most immediate risk to TDIV’s recent rally comes from the healthcare sector. Pfizer, the fund’s third-largest holding at 3.63% of the portfolio, reports quarterly results on Tuesday. Analysts are looking for earnings per share of $0.73. For the full year 2026, the drugmaker has guided for revenue between $59.5 billion and $62.5 billion, with adjusted EPS in a range of $2.80 to $3.00. A miss on either front could ripple through the ETF’s healthcare exposure, which accounts for just over 15% of assets.

The ten largest positions together represent more than 35% of the portfolio, meaning disappointment from any single heavyweight can weigh noticeably on overall performance.

TotalEnergies Provides a Tailwind

On the energy side, the picture is brighter. TotalEnergies — the seventh-largest holding at 3.06% — surprised to the upside last week. Quarterly earnings per share came in at $2.45, beating consensus by $0.23. Adjusted net income rose to €5.4 billion, a jump of more than 40% from the year-ago quarter, while operating cash flow hit €8.6 billion. With the energy sector making up 17.89% of TDIV, those strong numbers provide a cushion.

The Fed’s Fractured Message

The US Federal Reserve held its benchmark rate steady at 3.5% to 3.75% at its April meeting, the third consecutive pause. That was widely expected. What caught markets off guard was the scale of dissent: four FOMC members voted against the decision. Stephen Miran pushed for a 25-basis-point cut, while three others objected to language signaling future easing. It marked the first time since October 1992 that so many committee members dissented simultaneously.

For TDIV, the implications are direct. Financials are the fund’s largest sector weight at 31.58%, and uncertainty around the rate path hits that exposure hardest. Futures markets currently price the fed funds rate at around 3.6% through early 2027. J.P. Morgan Global Research expects the Fed to hold steady through 2026, with a single 25-basis-point hike arriving in the third quarter of 2027.

US employment data for April, due Friday May 8, will be the next test. March saw 178,000 new jobs added. A weak print could revive rate-cut speculation and support dividend stocks; a strong one would reinforce the pause.

A June Crossroads

Income-focused investors are already looking ahead to June. TDIV’s next quarterly dividend — following the €0.21 per share payout in March — has an ex-date of June 4, with payment scheduled for June 11. Over the trailing twelve months, the fund distributed €1.74 per share, with average dividend growth of nearly 17% over three years.

June also brings the semi-annual rebalancing of the underlying Morningstar index, which can trigger portfolio shifts. Adding to the complexity, BNP Paribas expects the European Central Bank to deliver a 25-basis-point rate hike in June — precisely when the rebalancing occurs. Eurozone inflation stood at 3.0% in April, while first-quarter GDP growth slowed to 0.8% year-on-year.

Technical Signals Flash Caution

The relative strength index for TDIV currently sits at 85.8, a level that technically signals overbought conditions. Whether Pfizer’s numbers on Tuesday can sustain the fund at these elevated levels will be the first real test of the week.

Dividend funds attracted roughly $24 billion in net inflows during the first quarter of 2026, the strongest quarterly showing in four years. The MSCI All Country World ex-USA has outperformed the S&P 500 by double-digit percentage points over the past year. VanEck’s timing with the new ex-US product may prove fortuitous — demand for international dividend exposure is only just taking shape.